2025 Was Not About Breakthroughs. It Was About Convergence. If 2024 was about proving the possibility of new healthcare ideas, 2025 marked the year that these innovations, across biotech, genomics, diagnostics, digital...read more
Category - Precision medicine
Tempus Scoops Up OneOme’s Pharmacogenetics Assets as Precision Medicine Shakeout Continues
Tempus AI has acquired the pharmacogenetics assets of OneOme, a once-promising precision medicine startup that abruptly shut down earlier this year amid financial troubles. The deal marks the latest in a flurry of...read more
Abbott to acquire Exact Sciences
• Acquisition adds a new growth vertical to Abbott’s already high single-digit growth profile, gaining leadership in the fast-growing $60 billion U.S. cancer screening and precision oncology diagnostics segments•...read more
BEVIMI Launches: A New Bid to Bring Pharma-Grade Rigor to Brain Health
This past week, BEVIMI was officially announced. This new company aims to bring pharmaceutical-style rigor to the consumer brain-health market. Headquartered in Greenwich, Connecticut and led by co-founders Paul...read more
